Helen McArdle

Health Correspondent

Helen McArdle is the Health Correspondent for The Herald. She joined in 2008 and went on to become a news reporter and transport correspondent. Since 2020, her focus has been on the impact of the pandemic on the NHS. Ms McArdle’s journalism honours include News Story of the Year at the Medical Journalism Association awards and she was also named Health & Science Reporter of the Year at the British Journalism Awards in 2018 for The Herald’s coverage of NHS Tayside’s use of charity donations to cover general spending. She was named Specialist Reporter of the Year at the 2022 Scottish Press Awards and picked up the Stephen White Award for the Reporting of Science in a Non-Science Context at the Association for British Science Writers awards.

Helen McArdle is the Health Correspondent for The Herald. She joined in 2008 and went on to become a news reporter and transport correspondent. Since 2020, her focus has been on the impact of the pandemic on the NHS. Ms McArdle’s journalism honours include News Story of the Year at the Medical Journalism Association awards and she was also named Health & Science Reporter of the Year at the British Journalism Awards in 2018 for The Herald’s coverage of NHS Tayside’s use of charity donations to cover general spending. She was named Specialist Reporter of the Year at the 2022 Scottish Press Awards and picked up the Stephen White Award for the Reporting of Science in a Non-Science Context at the Association for British Science Writers awards.

Latest articles from Helen McArdle

Exclusive Kidney disease research in Scotland set to benefit from new deal with AstraZeneca

Research into three potential new medicines which can slow down the progress of chronic kidney disease and reduce the risk that patients require a transplant or dialysis will be backed by a new investment from AstraZeneca.  The Scottish Government said a "triple helix" partnership between the pharmaceutical giant, NHS Scotland, and researchers based at the universities of Glasgow and Dundee will help to accelerate clinical trials into the disease.

Scientists develop 'gel' that could transform access to drugs in poorer countries

A breakthrough material developed by scientists in Glasgow will make it easier to transport and store medicines including cancer treatments without the need for fridges or freezers. Researchers from the universities of Manchester, Glasgow and Warwick, have created a hydrogel – a material mostly made of water – that stabilises proteins at temperatures as high as 50°C.